Literature DB >> 28372892

Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment.

Chloë De Roo1, Sylvie Lierman2, Kelly Tilleman2, Karen Peynshaert3, Kevin Braeckmans4, Mirte Caanen5, Cornelius B Lambalk5, Steven Weyers2, Guy T'Sjoen6, Ria Cornelissen7, Petra De Sutter2.   

Abstract

Female-to-male transgender people (trans men) are faced with the risk of losing their reproductive potential owing to gender-affirming hormone treatment and genital reconstructive surgery. This observational, prospective cohort study investigates the effect of prolonged androgen therapy on their ovarian histology and fertility preservation perspectives. Hormone serum levels, ovarian histology and cumulus-oocyte complexes (COC) of 40 trans men were analysed at the moment of hysterectomy with bilateral oophorectomy in the context of genital reconstructive surgery after testosterone treatment (58.18 ± 26.57 weeks). In the cortex, most follicles were primordial (68.52% total follicle count) compared with 20.26% intermediate and 10.74%primary follicles. Few secondary follicles (0.46%) and a single antral follicle were found in the sections analysed. In total, 1313 COC were retrieved from the medulla of 35 patients (37.51 ± 33.58 COC per patient). Anti-Müllerian hormone serum levels were significantly correlated with number of COC (Rs 0.787, P < 0.001). After 48 h in-vitro maturation, 34.30% metaphase II oocytes were obtained, with 87.10% having a normal spindle structure. In conclusion, the cortical follicle distribution in trans men, after more than a year of testosterone treatment, seems to be surprisingly normal. This work confirms the presence and in-vitro maturation potential of cumulus-oocyte complexes.
Copyright © 2017 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-Müllerian hormone; Cumulus-oocyte complex; Fertility preservation; In vitro maturation; Ovarian tissue; Transgender

Mesh:

Substances:

Year:  2017        PMID: 28372892     DOI: 10.1016/j.rbmo.2017.03.008

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  25 in total

1.  Ovarian stimulation outcomes among transgender men compared with fertile cisgender women.

Authors:  Hadar Amir; Iris Yaish; Nivin Samara; Joseph Hasson; Asnat Groutz; Foad Azem
Journal:  J Assist Reprod Genet       Date:  2020-07-28       Impact factor: 3.412

Review 2.  Systematic review of fertility preservation options in transgender patients: a guide for plastic surgeons.

Authors:  Maria Yan; Samyd S Bustos; Doga Kuruoglu; Pedro Ciudad; Antonio J Forte; Esther A Kim; Gabriel Del Corral; Oscar J Manrique
Journal:  Ann Transl Med       Date:  2021-04

Review 3.  Fertility preservation options in transgender people: A review.

Authors:  Natnita Mattawanon; Jessica B Spencer; David A Schirmer; Vin Tangpricha
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

4.  Fertility preservation for trans men: frozen-thawed in vitro matured oocytes collected at the time of ovarian tissue processing exhibit normal meiotic spindles.

Authors:  S Lierman; K Tilleman; K Braeckmans; K Peynshaert; S Weyers; G T'Sjoen; P De Sutter
Journal:  J Assist Reprod Genet       Date:  2017-06-24       Impact factor: 3.412

5.  Oocyte cryopreservation among transmasculine youth: a case series.

Authors:  Diane Chen; Lia A Bernardi; Mary Ellen Pavone; Eve C Feinberg; Molly B Moravek
Journal:  J Assist Reprod Genet       Date:  2018-08-22       Impact factor: 3.412

6.  Formative development of a fertility decision aid for transgender adolescents and young adults: a multidisciplinary Delphi consensus study.

Authors:  Victoria D Kolbuck; Afiya Sajwani; Moira A Kyweluk; Courtney Finlayson; Elisa J Gordon; Diane Chen
Journal:  J Assist Reprod Genet       Date:  2020-09-30       Impact factor: 3.412

Review 7.  Impact of Exogenous Testosterone on Reproduction in Transgender Men.

Authors:  Molly B Moravek; Hadrian M Kinnear; Jenny George; Jourdin Batchelor; Ariella Shikanov; Vasantha Padmanabhan; John F Randolph
Journal:  Endocrinology       Date:  2020-03-01       Impact factor: 4.736

Review 8.  Psychosocial challenges and hormonal treatment in gender diverse children and adolescents. A narrative review.

Authors:  Laura Baetens; Karlien Dhondt
Journal:  Int J Impot Res       Date:  2020-05-04       Impact factor: 2.896

Review 9.  Contraception across transgender.

Authors:  Ilaria Mancini; Stefania Alvisi; Giulia Gava; Renato Seracchioli; Maria Cristina Meriggiola
Journal:  Int J Impot Res       Date:  2021-02-08       Impact factor: 2.896

10.  Ethical issues involving fertility preservation for transgender youth.

Authors:  Rebecca M Harris; Irini N Kolaitis; Joel E Frader
Journal:  J Assist Reprod Genet       Date:  2020-08-11       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.